Fsme-Immun

Fsme-Immun is a vaccine designed to protect against tick-borne encephalitis. It contains the Neudoerfl strain of the virus, adsorbed on aluminium hydroxide, and is produced by Pfizer Spol. S R.O. in the EU.

Fsme-Immun is used for the prevention of tick-borne encephalitis, a viral infection transmitted by ticks. This vaccine is typically administered to individuals who are at risk of exposure to ticks, such as those who live in or travel to areas where the virus is endemic. The vaccine works by stimulating the body's immune response to the virus, helping to protect against future infections.

Common effects of Fsme-Immun may include mild soreness, redness, or swelling at the injection site. Some individuals may also experience mild fever, headache, or fatigue following vaccination. These effects are usually temporary and resolve on their own within a few days.

Fsme-Immun should be administered by a healthcare professional. It is important to inform your healthcare provider about any allergies or medical conditions before receiving the vaccine. Individuals with a history of severe allergic reactions to previous doses of the vaccine or any of its components should avoid receiving Fsme-Immun.

Fsme-Immun may interact with other medications or vaccines. It is advisable to discuss any current medications or recent vaccinations with a healthcare provider before receiving Fsme-Immun. Additionally, alcohol consumption should be avoided immediately before and after vaccination to minimize potential side effects.